About Evercore
Evercore is an investment bank founded in 1995. It is primarily based in Atlanta, United States. As of Apr 2026, Evercore has facilitated 1048 deals, comprising 886 M&A deals and 162 funding rounds. It has facilitated 59 deals in the last 12 months. It primarily facilitates Business Acquisition and PE deals for United States and United Kingdom based companies. The deals facilitated are spread across a wide range of sectors from Enterprise Applications to Financial Services. Most recently, it facilitated the $***** Seed round of Rowan Digital Infrastructure on Apr 07, 2026 and the acquisition of Learfield Communications by TPG on Apr 14, 2026. Apart from facilitating deals, Evercore has also invested in 9 companies and acquired 3 companies till Apr 2026.
Key Metrics
Founded Year
1995
Location
Atlanta, United States
No. of Deals facilitated
1048
No. of Deals facilitated in last 12 months
59
Top Deal Types
Business Acquisition, PE
Top Locations of Deals
Top Sectors of Deals
Funding Rounds Facilitated
M&A Facilitated
Recent Funding Deals facilitated by Evercore
Evercore has facilitated a total of 162 funding deals including Seed deals. The latest round that they facilitated was on Apr 07, 2026 for Rowan Digital Infrastructure in their Seed round of $*****.Their most notable funding round deals include a $***** Series B round of Acrisure. The investors in this round are Blackstone, Partners Group and 2 others.Here is the list of recent funding rounds facilitated by Evercore:
Date | Company | Round Name | Amount | Investors |
|---|---|---|---|---|
Apr 07, 2026 | Seed | 7781 | ||
Feb 02, 2026 | Unattributed | 2900 | ||
Jan 28, 2026 | Conventional Debt | 8202 | ||
Jan 28, 2026 | PE | 6751 |
Recent M&A Deals facilitated by Evercore
The latest M&A that they facilitated was on Apr 14, 2026 where Learfield Communications was acquired by TPG.Their most notable M&A deals include acquisition of Cidara Therapeutics by Merck.Here is the list of recent M&A deals facilitated by Evercore:
Date | Company | Amount | Acquirers | Co Facilitators |
|---|---|---|---|---|
Apr 14, 2026 | - | and 4 more | ||
Mar 30, 2026 | $29.1B | |||
Mar 26, 2026 | - | - | ||
Mar 13, 2026 | $12.1M |
Team profile of Evercore
Evercore has a team of 638 members including 263 Partners and 106 Principals located in United States, United Kingdom and 13 more locations. Evercore's team does not sit on the board of any company as of now.Here is a list of top team members in Evercore:
Name | Designation | Location | Contact Details |
|---|---|---|---|
Partner | Menlo Park | ||
Partner | New York City | ||
Partner | New York City | ||
Partner | New York City | ||
Partner | London | - | |
Partner | New York City | ||
Partner | New York City | ||
Partner | New York City | - | |
Partner | New York City | ||
Partner | Unadilla | ||
Partner | Chicago |
Evercore News
•
Tim: board of directors appoints advisor for Poste Italiane takeover bidFinanzaonline•Apr 14, 2026•Poste Italiane, BonelliErede, Gatti Pavesi Bianchi Ludovici, Gruppo TIM and 3 others
•
STG Raises $1.3 Billion for Oversubscribed STG Allegro II in Under Four MonthsBusiness Wire•Mar 04, 2026•STG, Evercore
•
Evommune Announces $125 Million Private PlacementFinancial Times•Feb 13, 2026•Evommune, Leerink Partners, Cantor Fitzgerald, Oppenheimer and 3 others
•
Vaxcyte Closes $632.5 Million Public Offering Including Underwriters' OptionGlobeNewswire•Feb 03, 2026•Vaxcyte, Leerink Partners, Guggenheim Securities, BTIG and 5 others
•
Erasca Closes Upsized Public Offering with Underwriters Exercising Full OptionGlobeNewswire•Jan 24, 2026•Erasca, Jefferies, Morgan Stanley, J P Morgan and 1 other
•
Glencore confirms in talks over possible merger with Rio TintoShareprices•Jan 09, 2026•Glencore, Rio Tinto, J P Morgan, Macquarie and 2 others
•
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common StockFinancial Times•Dec 17, 2025•Kodiak Sciences, Evercore, Jefferies, UBS and 1 other
•
George Osborne to Lead OpenAI's Global 'Stargate' AI Initiative.Business Matters•Dec 17, 2025•Evercore, OpenAI
•
Kodiak Sciences Announces Proposed Public Offering of Common StockPR Newswire•Dec 16, 2025•Kodiak Sciences, Evercore, Jefferies, UBS and 1 other
•
Vera Therapeutics Announces Pricing of Public Offering of Class A Common StockGlobeNewswire•Dec 10, 2025•Vera Therapeutics, Cantor Fitzgerald, Evercore, Goldman Sachs and 3 others
